|
US2005281785A1
|
|
Method of reducing side effects of cancer therapy using p53 recombinant adenovirus
|
|
KR20070118229A
|
|
The new use of recombinant adenovirus-p53 agent in treatment of tumor patients
|
|
AU2005326331A1
|
|
Recombined adenovirus p53 preparation for treating tumor
|
|
EP1642981A1
|
|
RECOMBINANT GENE MEDICINE OF ADENOVIRUS VECTOR AND GENE p53 FOR TREATING PROLIFERATIVE DISEASES
|
|
CA2518169A1
|
|
A recombinant constructed by a virus vector and a human tumor suppressor gene and its use
|
|
CN1401778A
|
|
Recombinant of viral vector and human tumor suppressor gene, and use thereof
|
